SRS Legal advises C2 Capital on Bluepharma investment (with Gustavo Ordonhas Oliveira, Marco Silva Garrinhas and Joana Ferreira Gonçalves)

«SRS Legal advised C2 Capital on a 30 million euro investment operation in Bluepharma, which resulted in C2 Capital becoming a reference shareholder in the pharmaceutical company.

"The SRS Legal team responsible for this operation involved a multidisciplinary team of lawyers in carrying out legal due diligence on Bluepharma and drafting and negotiating the investment contracts," said the law firm.

According to a statement from SRS Legal, this partnership between C2 Capital and Bluepharma aims to provide a substantial financial boost to advance Bluepharma's Bluepharma's strategic projects over the next decade.

The SRS Legal team responsible for providing advice was led by Gustavo Ordonhas Oliveira (partner), with Marco Silva Garrinhas (Managing Associate) and Joana Ferreira Gonçalves (associate).

According to SRS Legal, the 30 million euro investment aims to "reinforce Bluepharma's Research and Development (R&D) strategy, contributing to the industrial capacity of the pharmaceutical multinational based in Coimbra".

"The investment will play a crucial role in the solid progress of the "Coimbra Life Sciences Park" and CiNTech projects, which are part of the PRR (Resilience and Recovery Plan). Resilience and Recovery Plan). These projects aim to promote the creation and the first technological centre entirely dedicated to complex complex injectable medicines in Portugal," concludes SRS Legal.»